Sanchita Bhatnagar

Affiliations reported with papers

Linked publications

An evolutionary T119R substitution in the macaque T-cell immunoreceptor TIGIT enables proteolytic shedding and reveals clinical antibody vulnerabilities 2026

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy 2025

Targeting microRNA-dependent control of X chromosome inactivation improves the Rett Syndrome phenotype 2025

The TRIM37 variant rs57141087 contributes to triple-negative breast cancer outcomes in Black women 2025

Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer 2023

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors 2021

Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies 2021

Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer 2020

Targeting HER2 beyond breast cancer 2019

A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer 2018

Pharmacological reactivation of inactive X-linked Mecp2 in cerebral cortical neurons of living mice 2018

In Vitro Assay to Study Histone Ubiquitination During Transcriptional Regulation 2017

Related research

Human FasL, evolution and plasmin cleavage

A macaque TIGIT shedding difference

The regulatory Fas epitope

FOLR1-anchored DR5 bispecific antibody

DR5 agonism and PD-L1 immune evasion

Surface charge and DR5 antibody response

TRIM37 in breast-cancer outcomes

X-chromosome reactivation in Rett research